We agree with the American Diabetes Association (ADA) 2020 guidelines, which advise that, among patients with a systolic blood pressure ≥120 mmHg or a diastolic pressure ≥80 mmHg, such nonpharmacologic methods should be used to reduce blood pressure [33].